ARCHIVES

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

This article is from The Cancer Letter archive.

Vol. 40 No. 06 | February 7, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: NCAB Appointments: Boutwell Stay On; Brown, Elion, Strong, Korn Named; One Vacancy Remains

May 18, 1984

Emory’s Winship Cancer Institute Wins NCI Cancer Center Designation

April 17, 2009

Study Finds That CTC Was Used Correctly In Medicare Patients

April 26, 2013

Managed Care Plans Seek Cost Efficacy, Not Research, Center Directors Warned

March 17, 1995

NCI Advisory Group, Other Cancer Meetings

June 2, 1989

AACR Honors Scientists: Opens Web Sites

May 10, 1996